|
1
|
Lertkhachonsuk AA, Yip CH, Khuhaprema T,
Chen DS, Plummer M, Jee SH, Toi M and Wilailak S; Asian Oncology
Summit 2013, : Cancer prevention in Asia: Resource-stratified
guidelines from the Asian Oncology Summit, 2013. Lancet Oncol.
14:e497–e507. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stanley M: Pathology and epidemiology of
HPV infection in females. Gynecol Oncol 117 (2 Suppl). S5–S10.
2010. View Article : Google Scholar
|
|
3
|
Clifford GM, Smith JS, Plummer M, Muñoz N
and Franceschi S: Human papillomavirus types in invasive cervical
cancer worldwide: A meta-analysis. Br J Cancer. 88:63–73. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang J, Wei LH, Li YL, Wu RF, Xie X, Feng
YJ, Zhang G, Zhao C, Zhao Y and Chen Z: Detection of TERC
amplification in cervical epithelial cells for the diagnosis of
high-grade cervical lesions and invasive cancer: A multicenter
study in China. J Mol Diagn. 12:808–817. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geiger TR and Peeper DS: Metastasis
mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
|
|
7
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guarino M, Rubino B and Ballabio G: The
role of epithelial-mesenchymal transition in cancer pathology.
Pathology. 39:305–318. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhau HE, Odero-Marah V, Lue HW, Nomura T,
Wang R, Chu G, Liu ZR, Zhou BP, Huang WC and Chung LW: Epithelial
to mesenchymal transition (EMT) in human prostate cancer: Lessons
learned from ARCaP model. Clin Exp Metastasis. 25:601–610. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang MH, Chen CL, Chau GY, Chiou SH, Su
CW, Chou TY, Peng WL and Wu JC: Comprehensive analysis of the
independent effect of twist and snail in promoting metastasis of
hepatocellular carcinoma. Hepatology. 50:1464–1474. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gjerdrum C, Tiron C, Høiby T, Stefansson
I, Haugen H, Sandal T, Collett K, Li S, McCormack E, Gjertsen BT,
et al: Axl is an essential epithelial-to-mesenchymal
transition-induced regulator of breast cancer metastasis and
patient survival. Proc Natl Acad Sci USA. 107:1124–1129. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guarino M: Epithelial-mesenchymal
transition and tumour invasion. Int J Biochem Cell Biol.
39:2153–2160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Greenburg G and Hay ED: Epithelia
suspended in collagen gels can lose polarity and express
characteristics of migrating mesenchymal cells. J Cell Biol.
95:333–339. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kowalski PJ, Rubin MA and Kleer CG:
E-cadherin expression in primary carcinomas of the breast and its
distant metastases. Breast Cancer Res. 5:R217–R222. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ngan CY, Yamamoto H, Seshimo I, Tsujino T,
Man-i M, Ikeda JI, Konishi K, Takemasa I, Ikeda M, Sekimoto M, et
al: Quantitative evaluation of vimentin expression in tumour stroma
of colorectal cancer. Br J Cancer. 96:986–992. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liang J, Zhou H, Peng Y, Xie X, Li R, Liu
Y, Xie Q and Lin Z: β-catenin expression negatively correlates with
WIF1 and predicts poor clinical outcomes in patients with cervical
cancer. Biomed Res Int. 2016:49239032016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee MY, Chou CY, Tang MJ and Shen MR:
Epithelial-mesenchymal transition in cervical cancer: Correlation
with tumor progression, epidermal growth factor receptor
overexpression, and snail up-regulation. Clin Cancer Res.
14:4743–4750. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng Y, Zhou Y, Jiang W, Yang X, Zhu J,
Feng D, Wei Y, Li M, Yao F, Hu W, et al: Significance of
E-cadherin, β-catenin, and vimentin expression as postoperative
prognosis indicators in cervical squamous cell carcinoma. Hum
Pathol. 43:1213–1220. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li XL, Jiang J and Lu SY:
Epithelial-mesenchymal transition and gynecologic oncology. Chin J
Obstet Gynecol. 47:549–551. 2012.(In Chinese).
|
|
22
|
Chen X, Bode AM, Dong Z and Cao Y: The
epithelial-mesenchymal transition (EMT) is regulated by oncoviruses
in cancer. FASEB J. 30:3001–3010. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cyprian FS, Al-Farsi HF, Vranic S, Akhtar
S and Al Moustafa AE: Epstein-barr virus and human papillomaviruses
interactions and their roles in the initiation of
epithelial-mesenchymal transition and cancer progression. Fron
Oncol. 8:1112018. View Article : Google Scholar
|
|
24
|
Lapierre SG, Sauthier P, Mayrand MH,
Dufresne S, Petignat P, Provencher D, Drouin P, Gauthier P, Dupuis
MJ, Michon B, et al: Human papillomavirus (HPV) DNA triage of women
with atypical squamous cells of undetermined significance with
cobas 4800 HPV and Hybrid Capture 2 tests for detection of
high-grade lesions of the uterine cervix. J Clin Microbiol.
50:1240–1244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Benedet JL, Bender H, Jones H III, Ngan HY
and Pecorelli S: FIGO staging classifications and clinical practice
guidelines in the management of gynecologic cancers. FIGO committee
on gynecologic oncology. Int J Gynecol Obstet. 70:209–262. 2000.
View Article : Google Scholar
|
|
26
|
Lax SF, Horn LC and Löning T:
Categorization of uterine cervix tumors: What's new in the 2014 WHO
classification. Pathologe. 37:573–584. 2016.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Isidean SD, Coutlée F and Franco EL: cobas
4800 HPV Test, a real-time polymerase chain reaction assay for the
detection of human papillomavirus in cervical specimens. Expert Rev
Mol Diagn. 14:5–16. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jang TJ, Jung KH and Choi EA: Id-1 gene
downregulation by sulindac sulfide and its upregulation during
tumor development in gastric cancer. Int J Cancer. 118:1356–1363.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fedchenko N and Reifenrath J: Different
approaches for interpretation and reporting of immunohistochemistry
analysis results in the bone tissue-a review. Diagn Pathol.
9:2212014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi D, Jiang K, Fu Y, Fang R, Liu XI and
Chen J: Overexpression of SPARC correlates with poor prognosis in
patients with cervical carcinoma and regulates cancer cell
epithelial-mesenchymal transition. Oncol Lett. 11:3251–3258. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li B, Shi H, Wang F, Hong D, Lv W, Xie X
and Cheng X: Expression of E-, P- and N-cadherin and its clinical
significance in cervical squamous cell carcinoma and precancerous
lesions. PLoS One. 11:e01559102016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hazelbag S, Kenter GG, Gorter A, Dreef EJ,
Koopman LA, Violette SM, Weinreb PH and Fleuren GJ: Overexpression
of the alpha v beta 6 integrin in cervical squamous cell carcinoma
is a prognostic factor for decreased survival. J Pathol.
212:316–324. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stewart CJ and McCluggage WG:
Epithelial-mesenchymal transition in carcinomas of the female
genital tract. Histopathology. 62:31–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jeanes A, Gottardi CJ and Yap AS:
Cadherins and cancer: How does cadherin dysfunction promote tumor
progression? Oncogene. 27:6920–6929. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hazan RB, Qiao R, Keren R, Badano I and
Suyama K: Cadherin switch in tumor progression. Ann N Y Acad Sci.
1014:155–163. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hazan RB, Phillips GR, Qiao RF, Norton L
and Aaronson SA: Exogenous expression of N-cadherin in breast
cancer cells induces cell migration, invasion, and metastasis. J
Cell Biol. 148:779–790. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Costa LC, Leite CF, Cardoso SV, Loyola AM,
Faria PR, Souza PE and Horta MC: Expression of
epithelial-mesenchymal transition markers at the invasive front of
oral squamous cell carcinoma. J Appl Oral Sci. 23:169–178. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nakajima S, Doi R, Toyoda E, Tsuji S, Wada
M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, et al: N-cadherin
expression and epithelial-mesenchymal transition in pancreatic
carcinoma. Clin Cancer Res. 10:4125–4133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sun H, Liu M, Wu X, Yang C, Zhang Y, Xu Z,
Gao K and Wang F: Overexpression of N-cadherin and β-catenin
correlates with poor prognosis in patients with nasopharyngeal
carcinoma. Oncol Lett. 13:1725–1730. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Coulombe PA and Wong P: Cytoplasmic
intermediate filaments revealed as dynamic and multipurpose
scaffolds. Nat Cell Biol. 6:699–706. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lang SH, Hyde C, Reid IN, Hitchcock IS,
Hart CA, Bryden AA, Villette JM, Stower MJ and Maitland NJ:
Enhanced expression of vimentin in motile prostate cell lines and
in poorly differentiated and metastatic prostate carcinoma.
Prostate. 52:253–263. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Singh S, Sadacharan S, Su S, Belldegrun A,
Persad S and Singh G: Overexpression of vimentin: Role in the
invasive phenotype in an androgen-independent model of prostate
cancer. Cancer Res. 63:2306–2311. 2003.PubMed/NCBI
|
|
46
|
Liu CY, Lin HH, Tang MJ and Wang YK:
Vimentin contributes to epithelial-mesenchymal transition cancer
cell mechanics by mediating cytoskeletal organization and focal
adhesion maturation. Oncotarget. 6:15966–15983. 2015.PubMed/NCBI
|
|
47
|
Colomiere M, Findlay J, Ackland L and
Ahmed N: Epidermal growth factor-induced ovarian carcinoma cell
migration is associated with JAK2/STAT3 signals and changes in the
abundance and localization of alpha6beta1 integrin. Int J Biochem
Cell Biol. 41:1034–1045. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Vora HH, Patel NA, Rajvik KN, Mehta SV,
Brahmbhatt BV, Shah MJ, Shukla SN and Shah PM: Cytokeratin and
vimentin expression in breast cancer. Int J Biol Markers. 24:38–46.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shirahata A, Sakata M, Sakuraba K, Goto T,
Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and
Hibi K: Vimentin methylation as a marker for advanced colorectal
carcinoma. Anticancer Res. 29:279–281. 2009.PubMed/NCBI
|
|
50
|
Usami Y, Satake S, Nakayama F, Matsumoto
M, Ohnuma K, Komori T, Semba S, Ito A and Yokozaki H:
Snail-associated epithelial-mesenchymal transition promotes
oesophageal squamous cell carcinoma motility and progression. J
Pathol. 215:330–339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wei J, Xu G, Wu M, Zhang Y, Li Q, Liu P,
Zhu T, Song A, Zhao L, Han Z, et al: Overexpression of vimentin
contributes to prostate cancer invasion and metastasis via src
regulation. Anticancer Res. 28:327–334. 2008.PubMed/NCBI
|
|
52
|
Pankov R and Yamada KM: Fibronectin at a
glance. J Cell Sci. 115:3861–3863. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Birchler MT, Milisavlijevic D, Pfaltz M,
Neri D, Odermatt B, Schmid S and Stoeckli SJ: Expression of the
extra domain B of fibronectin, a marker of angiogenesis, in head
and neck tumors. Laryngoscope. 113:1231–1237. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Huang L, Zheng M, Liu JH, Xiong Y, Ding H,
Tang L and Wang HY: Risk factors and prognosis of IB-IIB cervical
carcinoma with common iliac lymph node metastasis. Chin J Cancer.
29:431–435. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li C, Liu W and Cheng Y: Prognostic
significance of metastatic lymph node ratio in squamous cell
carcinoma of the cervix. Onco Targets Ther. 9:3791–3797.
2016.PubMed/NCBI
|
|
56
|
Liu Y, Zhao LJ, Li MZ, Li MX, Wang JL and
Wei LH: The number of positive pelvic lymph nodes and multiple
groups of pelvic lymph node metastasis influence prognosis in stage
IA-IIB cervical squamous cell carcinoma. Chin Med J (Engl).
128:2084–2089. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ajila V, Shetty H, Babu S, Shetty V and
Hegde S: Human papilloma virus associated squamous cell carcinoma
of the head and neck. J Sex Transm Dis. 2015:7910242015.PubMed/NCBI
|
|
58
|
Bulk S, Berkhof J, Bulkmans NW, Zielinski
GD, Rozendaal L, van Kemenade FJ, Snijders PJ and Meijer CJ:
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18
for adenocarcinoma of the cervix compared to women with normal
cytology in The Netherlands. Br J Cancer. 94:171–175. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Cerasuolo A, Annunziata C, Tortora M,
Starita N, Stellato G, Greggi S, Maglione MG, Ionna F, Losito S,
Botti G, et al: Comparative analysis of HPV16 gene expression
profiles in cervical and in oropharyngeal squamous cell carcinoma.
Oncotarget. 8:34070–34081. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chen W, Zhang X, Molijn A, Jenkins D, Shi
JF, Quint W, Schmidt JE, Wang P, Liu YL, Li LK, et al: Human
papillomavirus type-distribution in cervical cancer in China: The
importance of HPV 16 and 18. Cancer Causes Control. 20:1705–1713.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Laurson J, Khan S, Chung R, Cross K and
Raj K: Epigenetic repression of E-cadherin by human papillomavirus
16 E7 protein. Carcinogenesis. 31:918–926. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cheng YM, Chou CY, Hsu YC, Chen MJ and
Wing LY: The role of human papillomavirus type 16 E6/E7
oncoproteins in cervical epithelial-mesenchymal transition and
carcinogenesis. Oncol Lett. 3:667–671. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hellner K, Mar J, Fang F, Quackenbush J
and Munger K: HPV16 E7 oncogene expression in normal human
epithelial cells causes molecular changes indicative of an
epithelial to mesenchymal transition. Virology. 391:57–63. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Caberg JH, Hubert PM, Begon DY, Herfs MF,
Roncarati PJ, Boniver JJ and Delvenne PO: Silencing of E7 oncogene
restores functional E-cadherin expression in human papillomavirus
16-transformed keratinocytes. Carcinogenesis. 29:1441–1447. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yang M, Wang M, Li X, Xie Y, Xia X, Tian
J, Zhang K and Tang A: Wnt signaling in cervical cancer? J Cancer.
9:1277–1286. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Bello JO, Nieva LO, Paredes AC, Gonzalez
AM, Zavaleta LR and Lizano M: Regulation of the Wnt/β-catenin
signaling pathway by human papillomavirus E6 and E7 oncoproteins.
Viruses. 7:4734–4755. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Sominsky S, Kuslansky Y, Shapiro B,
Jackman A, Haupt Y, Rosin-Arbesfeld R and Sherman L: HPV16 E6 and
E6AP differentially cooperate to stimulate or augment Wnt
signaling. Virology 468–470. 510–523. 2014. View Article : Google Scholar
|
|
68
|
Ghittoni R, Accardi R, Chiocca S and
Tommasino M: Role of human papillomaviruses in carcinogenesis.
Ecancermedicalscience. 9:5262015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Yeo-Teh NSL, Ito Y and Jha S: High-risk
human papillomaviral oncogenes E6 and E7 target key cellular
pathways to achieve oncogenesis. Int J Mol Sci. 19(pii): E17062018.
View Article : Google Scholar : PubMed/NCBI
|
